PrimeVigilance, an Ergomed company, has been
honoured with the prestigious Queen’s Award for
Enterprise which celebrates the success
of exciting and innovative UK businesses who
are committed to excellence.
PrimeVigilance, an Ergomed Group company,
employs over 500 highly qualified
professionals and offers competitive,
right-shoring solutions around the globe.
Providing regulatory services and clinical
development consultancy throughout the entire
life cycle of medical products with an international
team of qualified regulatory experts.
Part 2: Real-World Study Design, Methods and Use Cases
13 June 2019 – 15.00 GMT, 16.00 CEST, 11.00 EDT
PrimeVigilance & Ergomed experts Dr Michael Forstner,
Maartje Smulders and Dr Alex Artyomenko will be
speaking on this topic.
PrimeVigilance covers the entire product life cycle, assisting clients with the effective management of their drug safety information, and offering expert consulting services from former regulators and opinion leaders.
Offering optimal approaches to life cycle benefit-risk management by providing systematic risk minimisation and faster insights into the safety and effectiveness of drugs.
PrimeVigilance is a quality resource for concise, timely and accurate communication with highly trained, industry experienced healthcare professionals providing Medical Information
In partnership with our clients, PrimeVigilance is committed to improving patient health.
Our success begins with our people. Build your career in one of the most rewarding fields in the world.
+44 (0)1483 307920
(+1) 781 703 5540
United Kingdom (Head Office)